Pharmaceutical News

RSS

Drug prescribed for rare enzyme deficiency shows promise to treat herpes viruses

A drug currently prescribed to treat a rare enzyme deficiency can help cells clear the herpes simplex 1 and herpes simplex 2 viruses, according to a new study published in the journal Science Advances.

7 Dec 2020

West Health Policy Center forms CIDSA to provide independent analysis of drug pricing policies

The West Health Policy Center, a nonprofit and nonpartisan policy research and education organization, announced today the formation of the Council for Informed Drug Spending Analysis, a group made up entirely of leading policy experts from the worlds of academia and healthcare.

7 Dec 2020

Secukinumab for treatment of plaque psoriasis in children: Added benefit not proven

The monoclonal antibody secukinumab is approved for the treatment of moderate to severe plaque psoriasis in children and adolescents from the age of six years who are candidates for systemic therapy.

5 Dec 2020

Study shows metformin can significantly reduce COVID-19 death risks in women

University of Minnesota Medical School and UnitedHealth Group researchers found that metformin was associated with significantly reduced COVID-19 death risks in women in one of the world's largest observational studies of COVID-19 patients.

3 Dec 2020

FDA launches pilot program to help reduce and replace animal testing in drug development

This week, the U.S. Food and Drug Administration launched Innovative Science and Technology Approaches for New Drugs (ISTAND), a pilot program that will help reduce and replace animal testing as part of drug development.

3 Dec 2020

Can melatonin help prevent severe COVID-19?

A team of researchers at the University of Toronto in Canada has found that melatonin can be an adjuvant to augment the efficacy of anti-SARS-CoV-2 vaccines. They believe that the drug is a potential “silver bullet” to combat the COVID-19 pandemic.

3 Dec 2020

CUNY SPH launches new initiative to address public concerns about COVID-19 vaccines

The City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) today launched CONVINCE USAsm, part of a global project to increase understanding of factors that influence people's willingness to accept new COVID-19 vaccines, and to promote inclusive public dialogue to reduce vaccine hesitancy.

3 Dec 2020

Despite new CDC guidance, opioid prescription rates have not declined

Research from Saint Louis University finds that among patients at risk for opioid misuse, the odds of receiving a schedule II opioid for non-cancer pain were similar to those not at risk, despite new prescribing guidelines from the Centers for Disease Control (CDC).

2 Dec 2020

The UK approves Pfizer vaccine for December 2020 roll out

The UK approves Pfizer vaccine and schedules phased vaccination process, commencing December 2020.

2 Dec 2020

Mobile health app can improve HPV vaccine uptake in adolescents

More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals.

2 Dec 2020

Researchers develop first report card on biosimilars for three blockbuster cancer drugs

Researchers have developed the first report card on biosimilars for three blockbuster cancer drugs marketed by Genentech/Roche: Rituxan, Avastin, and Herceptin.

2 Dec 2020

Improved understanding of exposome-drug interactions could help prescribe effective drug doses

According to scientific estimations, humans are exposed to at least 10,000 to 100,000 environmental and exogenous compounds in an individual lifetime, which are mainly absorbed through our dietary.

2 Dec 2020

New combination therapy may help fight antimicrobial resistance

An inexpensive, FDA-approved drug -- cholestyramine -- taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according to new research by scientists at Penn State and the University of Michigan. The team's findings appear today (Dec. 1) in the journal eLife.

2 Dec 2020

Study evaluates the performance of meningococcus B vaccine in real-world setting

Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero.

2 Dec 2020

Glucosamine supplements may reduce overall mortality similar to regular exercise, shows study

Glucosamine supplements may reduce overall mortality about as well as regular exercise does, according to a new epidemiological study from West Virginia University.

2 Dec 2020

Smiling or grimacing can reduce the pain of needle injection by 40%

The coming of winter means cooler temperatures, shorter days and flu shots. While no one looks forward to a vaccination, a study led by the University of California, Irvine, has found that either a sincere smile or a grimace can reduce the pain of a needle injection by as much as 40 percent.

1 Dec 2020

OHDSI awarded $10 million FDA contract to support Biologics Effectiveness and Safety program

Researchers within the Observational Health Data Services and Informatics (OHDSI) community were recently awarded a $10 million contract from the U.S. Food and Drug Administration (FDA) to provide support to the Biologics Effectiveness and Safety (BEST) program, which was launched by the FDA Center for Biologics Evaluation and Research (CBER) in 2017.

1 Dec 2020

Medically active component of cannabis does not impact driving ability, study shows

A landmark study on how cannabis affects driving ability has shown that cannabidiol (CBD), a cannabis component now widely used for medical purposes, does not impair driving, while moderate amounts of the main intoxicating component tetrahydrocannabinol (THC) produce mild driving impairment lasting up to four hours.

1 Dec 2020

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.

1 Dec 2020

Mayo Clinic study identifies trends in statin use across the U.S.

People who have coronary artery disease, stroke or peripheral artery disease often are prescribed a statin, a cholesterol-lowering drug that reduces the risk of heart attack or stroke.

1 Dec 2020

Pharmaceutical News

Drug prescribed for rare enzyme deficiency shows promise to treat herpes viruses

West Health Policy Center forms CIDSA to provide independent analysis of drug pricing policies

Secukinumab for treatment of plaque psoriasis in children: Added benefit not proven

Study shows metformin can significantly reduce COVID-19 death risks in women

FDA launches pilot program to help reduce and replace animal testing in drug development

Can melatonin help prevent severe COVID-19?

CUNY SPH launches new initiative to address public concerns about COVID-19 vaccines

Despite new CDC guidance, opioid prescription rates have not declined

The UK approves Pfizer vaccine for December 2020 roll out

Mobile health app can improve HPV vaccine uptake in adolescents

Researchers develop first report card on biosimilars for three blockbuster cancer drugs

Improved understanding of exposome-drug interactions could help prescribe effective drug doses

New combination therapy may help fight antimicrobial resistance

Study evaluates the performance of meningococcus B vaccine in real-world setting

Glucosamine supplements may reduce overall mortality similar to regular exercise, shows study

Smiling or grimacing can reduce the pain of needle injection by 40%

OHDSI awarded $10 million FDA contract to support Biologics Effectiveness and Safety program

Medically active component of cannabis does not impact driving ability, study shows

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Mayo Clinic study identifies trends in statin use across the U.S.

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News